Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis-
Source: eagletribune.com
Wyeth Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wyeth Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wyeth Research Today - Breaking & Trending Today
Akari Therapeutics Announces the Appointment of John F. Neylan, III, MD as Executive Vice President, Chief Medical Officer
08.11.2022 - Dr. Neylan has more than 20 years of experience in the development of biologic treatments from pre-clinical to post-marketing trials across a broad range of therapeutic areas, including specialty and rare diseasesPrior to joining industry, Dr. ... Seite 1
Source: wallstreet-online.de
Investegate |Akari Therapeutics Plc Announcements | Akari Therapeutics Plc: Akari Therapeutics Announces the Appointment of John F. Neylan, III, MD as Executive Vice President, Chief Medical Officer
Investegate announcements from Akari Therapeutics Plc, Akari Therapeutics Announces the Appointment of John F. Neylan, III, MD as Executive Vice President, Chief Medical Officer
Source: investegate.co.uk
QurAlis Hires Key Regulatory Affairs, Clinical Operations, and Global Supply Chain Management Experts to Support Strategic Objectives
/PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other...
Source: prnewswire.com
QurAlis Hires Key Regulatory Affairs, Clinical Operations, and Global Supply Chain Management Experts to Support Strategic Objectives
CAMBRIDGE, Mass., Feb. 8, 2022 /PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic ...
Source: businessinsider.com